Downloads: 2 | Views: 198 | Weekly Hits: ⮙2 | Monthly Hits: ⮙2
Research Paper | Obstetrics and Gynecology | India | Volume 11 Issue 12, December 2022 | Popularity: 5.2 / 10
Acceptability and Compliance of Injectable Contraceptive DMPA [Depot Medroxy Progesterone Acetate] - A Prospective Observational Study in a Tertiary Care Hospital
Prof. Dr. R. Rajarajeswari, Dr. D. Nithya, Dr. R M. Shrimathi
Abstract: Background: India's population by 2050 is projected to reach 1.53 billion, making it the most populated country in theworld. As there is no ideal contraceptive which can appeal to all ages, health care providers should offer various options to the client who has a right to exercise her choice. The contraceptive prevalence of injectable contraception is 3.5% worldwide, whereas nationally the current use of DMPA is only 0.1%. The aim is to study the acceptability and compliance in women who seeks temporary contraception as DMPA. Methods: All 120 motivated and eligible women who chooses DMPA as a temporary contraceptive who fulfilled the inclusion and exclusion criteria were included in this study conducted in the Department of Obstetrics and Gynecology, at Government Raja MirasudharHospital, Thanjavur medical college over a period of 15 months. Women opting for DMPA injectable contraceptive during first nine months of the study period will be recruited in the study. Results: In this study, majority are in age group 26-30 years. Majority of the acceptors (40%) were Primiparous women, educated, belongs to postabortal period (65%). No previous contraception was used by many of the DMPA acceptors (64.2 % women). Irregular bleeding (36.7%) is the most common side effect. Most of the DMPA accepters discontinued after 1st injection (72.5%). The major reason for discontinuation was due to side effects (36.7%). Conclusion: Awareness of the patients about the benefits of DMPA over other contraceptives is must. Women needs to be educated so that they can avail access to wide range of contraceptives. DMPA should be considered a highly effective, safe, convenient contraceptive option for appropriately selected patients. If women are given reminders for their follow-up injections, it could increase regular and uninterrupted use of the injection.
Keywords: DMPA, ideal contraceptive, client,injectable, prevalence, acceptability, compliance,temporary contraceptive side effects, discontinuation
Edition: Volume 11 Issue 12, December 2022
Pages: 919 - 925
DOI: https://www.doi.org/10.21275/SR221220203636
Make Sure to Disable the Pop-Up Blocker of Web Browser
